nodes	percent_of_prediction	percent_of_DWPC	metapath
Isoprenaline—MAPK1—multiple sclerosis	0.704	1	CbGaD
Isoprenaline—ADRBK1—peripheral nervous system—multiple sclerosis	0.00676	0.13	CbGeAlD
Isoprenaline—PIK3R1—retina—multiple sclerosis	0.00316	0.0608	CbGeAlD
Isoprenaline—PIK3R2—nervous system—multiple sclerosis	0.00296	0.0569	CbGeAlD
Isoprenaline—PIK3R2—central nervous system—multiple sclerosis	0.00285	0.0548	CbGeAlD
Isoprenaline—PIK3R2—cerebellum—multiple sclerosis	0.00278	0.0536	CbGeAlD
Isoprenaline—PIK3R1—medulla oblongata—multiple sclerosis	0.00228	0.0439	CbGeAlD
Isoprenaline—PIK3R2—brain—multiple sclerosis	0.00226	0.0435	CbGeAlD
Isoprenaline—MAPK1—brainstem—multiple sclerosis	0.00223	0.043	CbGeAlD
Isoprenaline—PIK3R1—midbrain—multiple sclerosis	0.00209	0.0402	CbGeAlD
Isoprenaline—PIK3R1—spinal cord—multiple sclerosis	0.00203	0.0392	CbGeAlD
Isoprenaline—PIK3R3—nervous system—multiple sclerosis	0.00201	0.0386	CbGeAlD
Isoprenaline—PIK3R3—central nervous system—multiple sclerosis	0.00193	0.0372	CbGeAlD
Isoprenaline—PIK3R3—cerebellum—multiple sclerosis	0.00189	0.0364	CbGeAlD
Isoprenaline—PIK3R1—cerebellum—multiple sclerosis	0.00161	0.0311	CbGeAlD
Isoprenaline—PIK3R3—brain—multiple sclerosis	0.00153	0.0295	CbGeAlD
Isoprenaline—MAPK1—spinal cord—multiple sclerosis	0.00139	0.0267	CbGeAlD
Isoprenaline—PIK3R1—brain—multiple sclerosis	0.00131	0.0252	CbGeAlD
Isoprenaline—ADRBK1—nervous system—multiple sclerosis	0.00119	0.0228	CbGeAlD
Isoprenaline—MAPK1—nervous system—multiple sclerosis	0.00117	0.0225	CbGeAlD
Isoprenaline—ADRBK1—central nervous system—multiple sclerosis	0.00114	0.022	CbGeAlD
Isoprenaline—MAPK1—central nervous system—multiple sclerosis	0.00113	0.0217	CbGeAlD
Isoprenaline—ADRBK1—cerebellum—multiple sclerosis	0.00112	0.0215	CbGeAlD
Isoprenaline—Cardiac arrest—Fingolimod—multiple sclerosis	0.00111	0.0401	CcSEcCtD
Isoprenaline—MAPK1—cerebellum—multiple sclerosis	0.0011	0.0212	CbGeAlD
Isoprenaline—ADRBK1—brain—multiple sclerosis	0.000907	0.0175	CbGeAlD
Isoprenaline—MAPK1—brain—multiple sclerosis	0.000893	0.0172	CbGeAlD
Isoprenaline—Vision blurred—Fingolimod—multiple sclerosis	0.000665	0.0239	CcSEcCtD
Isoprenaline—Palpitations—Fingolimod—multiple sclerosis	0.000624	0.0225	CcSEcCtD
Isoprenaline—Hypertension—Fingolimod—multiple sclerosis	0.000609	0.0219	CcSEcCtD
Isoprenaline—Terbutaline—BCHE—multiple sclerosis	0.000594	0.754	CrCbGaD
Isoprenaline—Hypotension—Fingolimod—multiple sclerosis	0.000538	0.0194	CcSEcCtD
Isoprenaline—Dyspnoea—Fingolimod—multiple sclerosis	0.000514	0.0185	CcSEcCtD
Isoprenaline—ADRB1—nervous system—multiple sclerosis	0.000496	0.00955	CbGeAlD
Isoprenaline—ADRB1—central nervous system—multiple sclerosis	0.000478	0.0092	CbGeAlD
Isoprenaline—Pulmonary oedema—Prednisolone—multiple sclerosis	0.000439	0.0158	CcSEcCtD
Isoprenaline—Asthenia—Fingolimod—multiple sclerosis	0.000413	0.0149	CcSEcCtD
Isoprenaline—Arrhythmia—Cladribine—multiple sclerosis	0.000411	0.0148	CcSEcCtD
Isoprenaline—Pulmonary oedema—Triamcinolone—multiple sclerosis	0.000404	0.0145	CcSEcCtD
Isoprenaline—Pulmonary oedema—Methylprednisolone—multiple sclerosis	0.000403	0.0145	CcSEcCtD
Isoprenaline—Dizziness—Fingolimod—multiple sclerosis	0.000381	0.0137	CcSEcCtD
Isoprenaline—ADRB1—brain—multiple sclerosis	0.000379	0.0073	CbGeAlD
Isoprenaline—Pulmonary oedema—Dexamethasone—multiple sclerosis	0.000367	0.0132	CcSEcCtD
Isoprenaline—Pulmonary oedema—Betamethasone—multiple sclerosis	0.000367	0.0132	CcSEcCtD
Isoprenaline—Headache—Fingolimod—multiple sclerosis	0.000361	0.013	CcSEcCtD
Isoprenaline—Cardiac arrest—Prednisolone—multiple sclerosis	0.000341	0.0123	CcSEcCtD
Isoprenaline—Arrhythmia—Azathioprine—multiple sclerosis	0.000334	0.012	CcSEcCtD
Isoprenaline—Sweating—Mitoxantrone—multiple sclerosis	0.000323	0.0116	CcSEcCtD
Isoprenaline—CYP1A1—nervous system—multiple sclerosis	0.00032	0.00616	CbGeAlD
Isoprenaline—Pulmonary oedema—Prednisone—multiple sclerosis	0.000319	0.0115	CcSEcCtD
Isoprenaline—Tachycardia—Cladribine—multiple sclerosis	0.000319	0.0115	CcSEcCtD
Isoprenaline—Hyperhidrosis—Cladribine—multiple sclerosis	0.000316	0.0114	CcSEcCtD
Isoprenaline—Cardiac arrest—Triamcinolone—multiple sclerosis	0.000313	0.0113	CcSEcCtD
Isoprenaline—Cardiac arrest—Methylprednisolone—multiple sclerosis	0.000313	0.0113	CcSEcCtD
Isoprenaline—CYP1A1—central nervous system—multiple sclerosis	0.000308	0.00593	CbGeAlD
Isoprenaline—Hypotension—Cladribine—multiple sclerosis	0.000305	0.011	CcSEcCtD
Isoprenaline—Insomnia—Cladribine—multiple sclerosis	0.000295	0.0106	CcSEcCtD
Isoprenaline—Dyspnoea—Cladribine—multiple sclerosis	0.000291	0.0105	CcSEcCtD
Isoprenaline—Cardiac arrest—Betamethasone—multiple sclerosis	0.000284	0.0102	CcSEcCtD
Isoprenaline—Cardiac arrest—Dexamethasone—multiple sclerosis	0.000284	0.0102	CcSEcCtD
Isoprenaline—Bronchospasm—Methylprednisolone—multiple sclerosis	0.000279	0.0101	CcSEcCtD
Isoprenaline—Arrhythmia—Mitoxantrone—multiple sclerosis	0.00027	0.00972	CcSEcCtD
Isoprenaline—Pulmonary oedema—Methotrexate—multiple sclerosis	0.000267	0.00961	CcSEcCtD
Isoprenaline—Hypotension—Azathioprine—multiple sclerosis	0.000248	0.00893	CcSEcCtD
Isoprenaline—Vision blurred—Mitoxantrone—multiple sclerosis	0.000248	0.00892	CcSEcCtD
Isoprenaline—Cardiac arrest—Prednisone—multiple sclerosis	0.000248	0.00891	CcSEcCtD
Isoprenaline—CYP1A1—brain—multiple sclerosis	0.000245	0.00471	CbGeAlD
Isoprenaline—Sweating—Methylprednisolone—multiple sclerosis	0.000243	0.00874	CcSEcCtD
Isoprenaline—Asthenia—Cladribine—multiple sclerosis	0.000234	0.00844	CcSEcCtD
Isoprenaline—Convulsion—Mitoxantrone—multiple sclerosis	0.000228	0.0082	CcSEcCtD
Isoprenaline—Hypertension—Mitoxantrone—multiple sclerosis	0.000227	0.00818	CcSEcCtD
Isoprenaline—Arrhythmia—Prednisolone—multiple sclerosis	0.000221	0.00797	CcSEcCtD
Isoprenaline—Dizziness—Cladribine—multiple sclerosis	0.000216	0.00777	CcSEcCtD
Isoprenaline—Tachycardia—Mitoxantrone—multiple sclerosis	0.000209	0.00754	CcSEcCtD
Isoprenaline—Hyperhidrosis—Mitoxantrone—multiple sclerosis	0.000207	0.00747	CcSEcCtD
Isoprenaline—Headache—Cladribine—multiple sclerosis	0.000205	0.00737	CcSEcCtD
Isoprenaline—Arrhythmia—Triamcinolone—multiple sclerosis	0.000204	0.00733	CcSEcCtD
Isoprenaline—Vision blurred—Prednisolone—multiple sclerosis	0.000203	0.00732	CcSEcCtD
Isoprenaline—Arrhythmia—Methylprednisolone—multiple sclerosis	0.000203	0.00731	CcSEcCtD
Isoprenaline—Hypotension—Mitoxantrone—multiple sclerosis	0.000201	0.00722	CcSEcCtD
Isoprenaline—Nausea—Cladribine—multiple sclerosis	0.000194	0.00698	CcSEcCtD
Isoprenaline—Vertigo—Prednisolone—multiple sclerosis	0.000194	0.00698	CcSEcCtD
Isoprenaline—Epinephrine—TNF—multiple sclerosis	0.000193	0.246	CrCbGaD
Isoprenaline—Dyspnoea—Mitoxantrone—multiple sclerosis	0.000191	0.00689	CcSEcCtD
Isoprenaline—Convulsion—Prednisolone—multiple sclerosis	0.000187	0.00673	CcSEcCtD
Isoprenaline—Hypertension—Prednisolone—multiple sclerosis	0.000186	0.00671	CcSEcCtD
Isoprenaline—Arrhythmia—Betamethasone—multiple sclerosis	0.000185	0.00665	CcSEcCtD
Isoprenaline—Arrhythmia—Dexamethasone—multiple sclerosis	0.000185	0.00665	CcSEcCtD
Isoprenaline—Vertigo—Triamcinolone—multiple sclerosis	0.000178	0.00642	CcSEcCtD
Isoprenaline—Vertigo—Methylprednisolone—multiple sclerosis	0.000178	0.0064	CcSEcCtD
Isoprenaline—Dizziness—Azathioprine—multiple sclerosis	0.000176	0.00632	CcSEcCtD
Isoprenaline—Convulsion—Triamcinolone—multiple sclerosis	0.000172	0.00619	CcSEcCtD
Isoprenaline—Tachycardia—Prednisolone—multiple sclerosis	0.000172	0.00619	CcSEcCtD
Isoprenaline—Convulsion—Methylprednisolone—multiple sclerosis	0.000172	0.00618	CcSEcCtD
Isoprenaline—Hypertension—Triamcinolone—multiple sclerosis	0.000171	0.00617	CcSEcCtD
Isoprenaline—Hypertension—Methylprednisolone—multiple sclerosis	0.000171	0.00615	CcSEcCtD
Isoprenaline—Hyperhidrosis—Prednisolone—multiple sclerosis	0.00017	0.00613	CcSEcCtD
Isoprenaline—Flushing—Prednisone—multiple sclerosis	0.000167	0.00602	CcSEcCtD
Isoprenaline—Headache—Azathioprine—multiple sclerosis	0.000166	0.00599	CcSEcCtD
Isoprenaline—Vertigo—Betamethasone—multiple sclerosis	0.000162	0.00582	CcSEcCtD
Isoprenaline—Vertigo—Dexamethasone—multiple sclerosis	0.000162	0.00582	CcSEcCtD
Isoprenaline—Arrhythmia—Prednisone—multiple sclerosis	0.000161	0.00579	CcSEcCtD
Isoprenaline—Sweating—Methotrexate—multiple sclerosis	0.000161	0.00579	CcSEcCtD
Isoprenaline—Insomnia—Prednisolone—multiple sclerosis	0.000159	0.00573	CcSEcCtD
Isoprenaline—Tachycardia—Triamcinolone—multiple sclerosis	0.000158	0.00569	CcSEcCtD
Isoprenaline—Nausea—Azathioprine—multiple sclerosis	0.000158	0.00568	CcSEcCtD
Isoprenaline—Tachycardia—Methylprednisolone—multiple sclerosis	0.000158	0.00568	CcSEcCtD
Isoprenaline—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000157	0.00564	CcSEcCtD
Isoprenaline—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000156	0.00562	CcSEcCtD
Isoprenaline—Convulsion—Betamethasone—multiple sclerosis	0.000156	0.00562	CcSEcCtD
Isoprenaline—Convulsion—Dexamethasone—multiple sclerosis	0.000156	0.00562	CcSEcCtD
Isoprenaline—Hypertension—Dexamethasone—multiple sclerosis	0.000155	0.0056	CcSEcCtD
Isoprenaline—Hypertension—Betamethasone—multiple sclerosis	0.000155	0.0056	CcSEcCtD
Isoprenaline—Asthenia—Mitoxantrone—multiple sclerosis	0.000154	0.00554	CcSEcCtD
Isoprenaline—Hypotension—Methylprednisolone—multiple sclerosis	0.000151	0.00544	CcSEcCtD
Isoprenaline—Vision blurred—Prednisone—multiple sclerosis	0.000148	0.00532	CcSEcCtD
Isoprenaline—Insomnia—Triamcinolone—multiple sclerosis	0.000146	0.00527	CcSEcCtD
Isoprenaline—Insomnia—Methylprednisolone—multiple sclerosis	0.000146	0.00526	CcSEcCtD
Isoprenaline—Dyspnoea—Triamcinolone—multiple sclerosis	0.000144	0.0052	CcSEcCtD
Isoprenaline—Tachycardia—Dexamethasone—multiple sclerosis	0.000143	0.00516	CcSEcCtD
Isoprenaline—Tachycardia—Betamethasone—multiple sclerosis	0.000143	0.00516	CcSEcCtD
Isoprenaline—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000142	0.00511	CcSEcCtD
Isoprenaline—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000142	0.00511	CcSEcCtD
Isoprenaline—Vertigo—Prednisone—multiple sclerosis	0.000141	0.00507	CcSEcCtD
Isoprenaline—Hypotension—Betamethasone—multiple sclerosis	0.000137	0.00494	CcSEcCtD
Isoprenaline—Hypotension—Dexamethasone—multiple sclerosis	0.000137	0.00494	CcSEcCtD
Isoprenaline—Convulsion—Prednisone—multiple sclerosis	0.000136	0.00489	CcSEcCtD
Isoprenaline—Hypertension—Prednisone—multiple sclerosis	0.000135	0.00487	CcSEcCtD
Isoprenaline—Headache—Mitoxantrone—multiple sclerosis	0.000134	0.00484	CcSEcCtD
Isoprenaline—Insomnia—Dexamethasone—multiple sclerosis	0.000133	0.00478	CcSEcCtD
Isoprenaline—Insomnia—Betamethasone—multiple sclerosis	0.000133	0.00478	CcSEcCtD
Isoprenaline—Nausea—Mitoxantrone—multiple sclerosis	0.000127	0.00459	CcSEcCtD
Isoprenaline—Tachycardia—Prednisone—multiple sclerosis	0.000125	0.0045	CcSEcCtD
Isoprenaline—Hyperhidrosis—Prednisone—multiple sclerosis	0.000124	0.00445	CcSEcCtD
Isoprenaline—Vision blurred—Methotrexate—multiple sclerosis	0.000123	0.00445	CcSEcCtD
Isoprenaline—Vertigo—Methotrexate—multiple sclerosis	0.000118	0.00424	CcSEcCtD
Isoprenaline—Dizziness—Prednisolone—multiple sclerosis	0.000116	0.00419	CcSEcCtD
Isoprenaline—Asthenia—Triamcinolone—multiple sclerosis	0.000116	0.00418	CcSEcCtD
Isoprenaline—Asthenia—Methylprednisolone—multiple sclerosis	0.000116	0.00417	CcSEcCtD
Isoprenaline—Insomnia—Prednisone—multiple sclerosis	0.000116	0.00417	CcSEcCtD
Isoprenaline—Convulsion—Methotrexate—multiple sclerosis	0.000114	0.00409	CcSEcCtD
Isoprenaline—Headache—Prednisolone—multiple sclerosis	0.00011	0.00397	CcSEcCtD
Isoprenaline—Dizziness—Triamcinolone—multiple sclerosis	0.000107	0.00386	CcSEcCtD
Isoprenaline—Dizziness—Methylprednisolone—multiple sclerosis	0.000107	0.00385	CcSEcCtD
Isoprenaline—Asthenia—Betamethasone—multiple sclerosis	0.000105	0.0038	CcSEcCtD
Isoprenaline—Asthenia—Dexamethasone—multiple sclerosis	0.000105	0.0038	CcSEcCtD
Isoprenaline—Nausea—Prednisolone—multiple sclerosis	0.000105	0.00377	CcSEcCtD
Isoprenaline—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000103	0.00372	CcSEcCtD
Isoprenaline—Headache—Triamcinolone—multiple sclerosis	0.000101	0.00365	CcSEcCtD
Isoprenaline—Headache—Methylprednisolone—multiple sclerosis	0.000101	0.00364	CcSEcCtD
Isoprenaline—Hypotension—Methotrexate—multiple sclerosis	9.99e-05	0.0036	CcSEcCtD
Isoprenaline—Dizziness—Betamethasone—multiple sclerosis	9.72e-05	0.0035	CcSEcCtD
Isoprenaline—Dizziness—Dexamethasone—multiple sclerosis	9.72e-05	0.0035	CcSEcCtD
Isoprenaline—Insomnia—Methotrexate—multiple sclerosis	9.67e-05	0.00348	CcSEcCtD
Isoprenaline—Nausea—Triamcinolone—multiple sclerosis	9.62e-05	0.00346	CcSEcCtD
Isoprenaline—Nausea—Methylprednisolone—multiple sclerosis	9.6e-05	0.00346	CcSEcCtD
Isoprenaline—Dyspnoea—Methotrexate—multiple sclerosis	9.53e-05	0.00343	CcSEcCtD
Isoprenaline—Headache—Dexamethasone—multiple sclerosis	9.2e-05	0.00331	CcSEcCtD
Isoprenaline—Headache—Betamethasone—multiple sclerosis	9.2e-05	0.00331	CcSEcCtD
Isoprenaline—Asthenia—Prednisone—multiple sclerosis	9.18e-05	0.00331	CcSEcCtD
Isoprenaline—Nausea—Betamethasone—multiple sclerosis	8.73e-05	0.00314	CcSEcCtD
Isoprenaline—Nausea—Dexamethasone—multiple sclerosis	8.73e-05	0.00314	CcSEcCtD
Isoprenaline—Dizziness—Prednisone—multiple sclerosis	8.46e-05	0.00305	CcSEcCtD
Isoprenaline—Headache—Prednisone—multiple sclerosis	8.02e-05	0.00289	CcSEcCtD
Isoprenaline—Asthenia—Methotrexate—multiple sclerosis	7.67e-05	0.00276	CcSEcCtD
Isoprenaline—Nausea—Prednisone—multiple sclerosis	7.6e-05	0.00274	CcSEcCtD
Isoprenaline—Dizziness—Methotrexate—multiple sclerosis	7.07e-05	0.00255	CcSEcCtD
Isoprenaline—Headache—Methotrexate—multiple sclerosis	6.7e-05	0.00241	CcSEcCtD
Isoprenaline—Nausea—Methotrexate—multiple sclerosis	6.35e-05	0.00229	CcSEcCtD
Isoprenaline—MAPK1—Signaling Pathways—CD28—multiple sclerosis	8.23e-06	3.81e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—TYK2—multiple sclerosis	8.23e-06	3.81e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—CCL5—multiple sclerosis	8.16e-06	3.78e-05	CbGpPWpGaD
Isoprenaline—ADRB1—GPCR downstream signaling—IL2RA—multiple sclerosis	8.15e-06	3.78e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Immune System—MAPK1—multiple sclerosis	8.11e-06	3.76e-05	CbGpPWpGaD
Isoprenaline—ADRB2—GPCR downstream signaling—CCR5—multiple sclerosis	8.09e-06	3.75e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—CCR2—multiple sclerosis	8.08e-06	3.74e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Metabolism—ALB—multiple sclerosis	8.06e-06	3.73e-05	CbGpPWpGaD
Isoprenaline—ADRB3—GPCR downstream signaling—IL2—multiple sclerosis	8.05e-06	3.73e-05	CbGpPWpGaD
Isoprenaline—ADRB2—GPCR downstream signaling—IL2RA—multiple sclerosis	7.98e-06	3.7e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—IL2RA—multiple sclerosis	7.94e-06	3.68e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—SPP1—multiple sclerosis	7.88e-06	3.65e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—HLA-A—multiple sclerosis	7.85e-06	3.64e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—CD80—multiple sclerosis	7.78e-06	3.6e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—IFNG—multiple sclerosis	7.71e-06	3.57e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—SPP1—multiple sclerosis	7.69e-06	3.56e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—CD80—multiple sclerosis	7.66e-06	3.55e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—CCR5—multiple sclerosis	7.66e-06	3.55e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Disease—MYC—multiple sclerosis	7.65e-06	3.55e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Disease—TGFB1—multiple sclerosis	7.63e-06	3.54e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—CCL3—multiple sclerosis	7.62e-06	3.53e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Developmental Biology—STAT3—multiple sclerosis	7.61e-06	3.53e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—TYK2—multiple sclerosis	7.6e-06	3.52e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—IL2RA—multiple sclerosis	7.55e-06	3.5e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—CCR5—multiple sclerosis	7.51e-06	3.48e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling by GPCR—IL2—multiple sclerosis	7.49e-06	3.47e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Disease—MAPK1—multiple sclerosis	7.49e-06	3.47e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—CCR5—multiple sclerosis	7.48e-06	3.46e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—CNR1—multiple sclerosis	7.46e-06	3.46e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Axon guidance—IL6—multiple sclerosis	7.45e-06	3.45e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—CCL3—multiple sclerosis	7.45e-06	3.45e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—CD4—multiple sclerosis	7.44e-06	3.45e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—CCR5—multiple sclerosis	7.44e-06	3.45e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—IL2RA—multiple sclerosis	7.41e-06	3.43e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—POMC—multiple sclerosis	7.39e-06	3.42e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—IL2RA—multiple sclerosis	7.37e-06	3.41e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—CCR5—multiple sclerosis	7.35e-06	3.41e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—PTGER4—multiple sclerosis	7.33e-06	3.4e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Cell Cycle, Mitotic—MYC—multiple sclerosis	7.33e-06	3.39e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling by GPCR—IL2—multiple sclerosis	7.31e-06	3.39e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—POMC—multiple sclerosis	7.28e-06	3.37e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—HLA-A—multiple sclerosis	7.25e-06	3.36e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—IL2RA—multiple sclerosis	7.24e-06	3.36e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—CCL2—multiple sclerosis	7.23e-06	3.35e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—PGR—multiple sclerosis	7.22e-06	3.35e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—TLR4—multiple sclerosis	7.18e-06	3.33e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—PTGER4—multiple sclerosis	7.17e-06	3.32e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—HLA-DRB1—multiple sclerosis	7.17e-06	3.32e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Metabolism—POMC—multiple sclerosis	7.16e-06	3.32e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—CCL2—multiple sclerosis	7.12e-06	3.3e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Immune System—STAT3—multiple sclerosis	7.11e-06	3.29e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—CXCR3—multiple sclerosis	7.08e-06	3.28e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling by GPCR—MAPK1—multiple sclerosis	7.07e-06	3.28e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—PGR—multiple sclerosis	7.06e-06	3.27e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	7.06e-06	3.27e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Developmental Biology—TGFB1—multiple sclerosis	7.06e-06	3.27e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—CD28—multiple sclerosis	7.01e-06	3.25e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Immune System—STAT3—multiple sclerosis	7e-06	3.25e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—APOE—multiple sclerosis	6.97e-06	3.23e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling by GPCR—MAPK1—multiple sclerosis	6.97e-06	3.23e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—CXCR3—multiple sclerosis	6.93e-06	3.21e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Hemostasis—TGFB1—multiple sclerosis	6.92e-06	3.21e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Innate Immune System—IL6—multiple sclerosis	6.91e-06	3.2e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—POMC—multiple sclerosis	6.89e-06	3.19e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—CCR2—multiple sclerosis	6.89e-06	3.19e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—ICAM1—multiple sclerosis	6.88e-06	3.19e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—IL1B—multiple sclerosis	6.87e-06	3.18e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—CD4—multiple sclerosis	6.87e-06	3.18e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—CD28—multiple sclerosis	6.86e-06	3.18e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—IL2—multiple sclerosis	6.85e-06	3.18e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—IL2—multiple sclerosis	6.85e-06	3.17e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling by GPCR—IL6—multiple sclerosis	6.82e-06	3.16e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—APOE—multiple sclerosis	6.8e-06	3.15e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—APOE—multiple sclerosis	6.77e-06	3.13e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—CCL2—multiple sclerosis	6.74e-06	3.12e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—CCR2—multiple sclerosis	6.74e-06	3.12e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—CXCL10—multiple sclerosis	6.72e-06	3.11e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—CD80—multiple sclerosis	6.63e-06	3.07e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Developmental Biology—TNF—multiple sclerosis	6.59e-06	3.05e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—TYK2—multiple sclerosis	6.57e-06	3.04e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Disease—STAT3—multiple sclerosis	6.57e-06	3.04e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Cell Cycle—MYC—multiple sclerosis	6.55e-06	3.03e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Metabolism—ALB—multiple sclerosis	6.53e-06	3.02e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—MMP9—multiple sclerosis	6.49e-06	3.01e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—TYK2—multiple sclerosis	6.47e-06	3e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Disease—STAT3—multiple sclerosis	6.47e-06	3e-05	CbGpPWpGaD
Isoprenaline—ADRB1—GPCR downstream signaling—POMC—multiple sclerosis	6.47e-06	3e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Immune System—MAPK1—multiple sclerosis	6.46e-06	3e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Immune System—MAPK1—multiple sclerosis	6.37e-06	2.95e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—CNR1—multiple sclerosis	6.36e-06	2.95e-05	CbGpPWpGaD
Isoprenaline—ADRB2—GPCR downstream signaling—POMC—multiple sclerosis	6.33e-06	2.93e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—CD80—multiple sclerosis	6.3e-06	2.92e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Immune System—IL6—multiple sclerosis	6.23e-06	2.89e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—CNR1—multiple sclerosis	6.22e-06	2.88e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—CD80—multiple sclerosis	6.15e-06	2.85e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—TYK2—multiple sclerosis	6.12e-06	2.84e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—CD80—multiple sclerosis	6.12e-06	2.83e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Disease—MYC—multiple sclerosis	6.1e-06	2.83e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Disease—TGFB1—multiple sclerosis	6.09e-06	2.82e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	6.06e-06	2.81e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Disease—MYC—multiple sclerosis	6.01e-06	2.78e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Disease—TGFB1—multiple sclerosis	5.99e-06	2.78e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—POMC—multiple sclerosis	5.99e-06	2.77e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Disease—MAPK1—multiple sclerosis	5.97e-06	2.77e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Disease—MAPK1—multiple sclerosis	5.88e-06	2.72e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—POMC—multiple sclerosis	5.87e-06	2.72e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—CD86—multiple sclerosis	5.87e-06	2.72e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—CCL2—multiple sclerosis	5.86e-06	2.71e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—POMC—multiple sclerosis	5.84e-06	2.71e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—CCL5—multiple sclerosis	5.78e-06	2.68e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—STAT3—multiple sclerosis	5.77e-06	2.67e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—STAT3—multiple sclerosis	5.76e-06	2.67e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Disease—IL6—multiple sclerosis	5.75e-06	2.67e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—CCL2—multiple sclerosis	5.75e-06	2.66e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—POMC—multiple sclerosis	5.74e-06	2.66e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling by GPCR—MAPK1—multiple sclerosis	5.73e-06	2.66e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—CXCL10—multiple sclerosis	5.72e-06	2.65e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—CCL2—multiple sclerosis	5.72e-06	2.65e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—CCL2—multiple sclerosis	5.62e-06	2.6e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—CXCL10—multiple sclerosis	5.6e-06	2.59e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling by GPCR—MAPK1—multiple sclerosis	5.59e-06	2.59e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—TYK2—multiple sclerosis	5.59e-06	2.59e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	5.53e-06	2.56e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—IL2—multiple sclerosis	5.46e-06	2.53e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling by GPCR—IL6—multiple sclerosis	5.44e-06	2.52e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—IL2—multiple sclerosis	5.38e-06	2.49e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—MYC—multiple sclerosis	5.36e-06	2.48e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling by GPCR—IL6—multiple sclerosis	5.35e-06	2.48e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—SPP1—multiple sclerosis	5.35e-06	2.48e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—TGFB1—multiple sclerosis	5.35e-06	2.48e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—TYK2—multiple sclerosis	5.32e-06	2.46e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—STAT3—multiple sclerosis	5.32e-06	2.46e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Developmental Biology—IL6—multiple sclerosis	5.32e-06	2.46e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—MAPK1—multiple sclerosis	5.24e-06	2.43e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—MAPK1—multiple sclerosis	5.24e-06	2.43e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—IFNG—multiple sclerosis	5.24e-06	2.43e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—BCHE—multiple sclerosis	5.22e-06	2.42e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—TYK2—multiple sclerosis	5.22e-06	2.42e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—CCR5—multiple sclerosis	5.21e-06	2.41e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—TYK2—multiple sclerosis	5.19e-06	2.41e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—MMP9—multiple sclerosis	5.17e-06	2.4e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—TYK2—multiple sclerosis	5.16e-06	2.39e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—IL2RA—multiple sclerosis	5.13e-06	2.38e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—TYK2—multiple sclerosis	5.1e-06	2.36e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—IL2—multiple sclerosis	5.09e-06	2.36e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—MMP9—multiple sclerosis	5.09e-06	2.36e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—CD4—multiple sclerosis	5.06e-06	2.34e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—CD86—multiple sclerosis	5e-06	2.32e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Immune System—IL6—multiple sclerosis	4.97e-06	2.3e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—MYC—multiple sclerosis	4.94e-06	2.29e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—TGFB1—multiple sclerosis	4.93e-06	2.28e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—CCL5—multiple sclerosis	4.93e-06	2.28e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—CD86—multiple sclerosis	4.9e-06	2.27e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Immune System—IL6—multiple sclerosis	4.89e-06	2.27e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—MAPK1—multiple sclerosis	4.84e-06	2.24e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—CCL5—multiple sclerosis	4.82e-06	2.23e-05	CbGpPWpGaD
Isoprenaline—ADRB1—GPCR downstream signaling—IL2—multiple sclerosis	4.78e-06	2.21e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—APOE—multiple sclerosis	4.74e-06	2.2e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Innate Immune System—IL6—multiple sclerosis	4.7e-06	2.18e-05	CbGpPWpGaD
Isoprenaline—ADRB2—GPCR downstream signaling—IL2—multiple sclerosis	4.68e-06	2.17e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—IL1B—multiple sclerosis	4.67e-06	2.16e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—CD4—multiple sclerosis	4.67e-06	2.16e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—IL2—multiple sclerosis	4.65e-06	2.16e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—STAT3—multiple sclerosis	4.6e-06	2.13e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Disease—IL6—multiple sclerosis	4.59e-06	2.12e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—SPP1—multiple sclerosis	4.56e-06	2.11e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—STAT3—multiple sclerosis	4.53e-06	2.1e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Disease—IL6—multiple sclerosis	4.52e-06	2.09e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—SPP1—multiple sclerosis	4.46e-06	2.07e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—CCR5—multiple sclerosis	4.44e-06	2.06e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—IL2—multiple sclerosis	4.43e-06	2.05e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling by GPCR—IL6—multiple sclerosis	4.4e-06	2.04e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—IL2RA—multiple sclerosis	4.37e-06	2.03e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—CCR5—multiple sclerosis	4.34e-06	2.01e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—IL2—multiple sclerosis	4.34e-06	2.01e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—IL2—multiple sclerosis	4.32e-06	2e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling by GPCR—IL6—multiple sclerosis	4.3e-06	1.99e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—CD80—multiple sclerosis	4.28e-06	1.98e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—IL2RA—multiple sclerosis	4.28e-06	1.98e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—MYC—multiple sclerosis	4.27e-06	1.98e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—TGFB1—multiple sclerosis	4.26e-06	1.97e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—IL2—multiple sclerosis	4.25e-06	1.97e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—MYC—multiple sclerosis	4.21e-06	1.95e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—TGFB1—multiple sclerosis	4.2e-06	1.95e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—MMP9—multiple sclerosis	4.19e-06	1.94e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—MAPK1—multiple sclerosis	4.18e-06	1.94e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—MAPK1—multiple sclerosis	4.12e-06	1.91e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—MMP9—multiple sclerosis	4.09e-06	1.89e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—POMC—multiple sclerosis	4.07e-06	1.89e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—APOE—multiple sclerosis	4.04e-06	1.87e-05	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—IL6—multiple sclerosis	4.03e-06	1.87e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—IL6—multiple sclerosis	4.02e-06	1.86e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—CCL2—multiple sclerosis	3.98e-06	1.85e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—APOE—multiple sclerosis	3.95e-06	1.83e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—STAT3—multiple sclerosis	3.92e-06	1.81e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—STAT3—multiple sclerosis	3.73e-06	1.73e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—IL6—multiple sclerosis	3.72e-06	1.72e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—CD80—multiple sclerosis	3.65e-06	1.69e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—STAT3—multiple sclerosis	3.64e-06	1.68e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—TYK2—multiple sclerosis	3.62e-06	1.68e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—STAT3—multiple sclerosis	3.62e-06	1.68e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—CD80—multiple sclerosis	3.57e-06	1.65e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—POMC—multiple sclerosis	3.47e-06	1.61e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—MYC—multiple sclerosis	3.46e-06	1.6e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—TGFB1—multiple sclerosis	3.45e-06	1.6e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—CCL2—multiple sclerosis	3.39e-06	1.57e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—POMC—multiple sclerosis	3.39e-06	1.57e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—MAPK1—multiple sclerosis	3.39e-06	1.57e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—MYC—multiple sclerosis	3.38e-06	1.57e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—TGFB1—multiple sclerosis	3.37e-06	1.56e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—MYC—multiple sclerosis	3.36e-06	1.56e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—TGFB1—multiple sclerosis	3.35e-06	1.55e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—MAPK1—multiple sclerosis	3.32e-06	1.54e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—CCL2—multiple sclerosis	3.32e-06	1.54e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—MAPK1—multiple sclerosis	3.31e-06	1.53e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—MAPK1—multiple sclerosis	3.25e-06	1.51e-05	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—IL6—multiple sclerosis	3.21e-06	1.49e-05	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—IL6—multiple sclerosis	3.16e-06	1.47e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—APOE—multiple sclerosis	3.14e-06	1.46e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—TYK2—multiple sclerosis	3.08e-06	1.43e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—TYK2—multiple sclerosis	3.01e-06	1.4e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—IL2—multiple sclerosis	3.01e-06	1.39e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—IL6—multiple sclerosis	2.99e-06	1.39e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—MMP9—multiple sclerosis	2.85e-06	1.32e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—IL6—multiple sclerosis	2.74e-06	1.27e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—POMC—multiple sclerosis	2.7e-06	1.25e-05	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—IL6—multiple sclerosis	2.6e-06	1.21e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—IL2—multiple sclerosis	2.56e-06	1.19e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—IL6—multiple sclerosis	2.55e-06	1.18e-05	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—IL6—multiple sclerosis	2.54e-06	1.18e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—STAT3—multiple sclerosis	2.53e-06	1.17e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—IL6—multiple sclerosis	2.53e-06	1.17e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—IL2—multiple sclerosis	2.51e-06	1.16e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—IL6—multiple sclerosis	2.5e-06	1.16e-05	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—ALB—multiple sclerosis	2.46e-06	1.14e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—MMP9—multiple sclerosis	2.43e-06	1.12e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—MMP9—multiple sclerosis	2.37e-06	1.1e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—MYC—multiple sclerosis	2.35e-06	1.09e-05	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—TGFB1—multiple sclerosis	2.35e-06	1.09e-05	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—STAT3—multiple sclerosis	2.16e-06	1e-05	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—STAT3—multiple sclerosis	2.11e-06	9.78e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—MYC—multiple sclerosis	2.01e-06	9.29e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—TGFB1—multiple sclerosis	2e-06	9.27e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—MAPK1—multiple sclerosis	1.96e-06	9.09e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—MYC—multiple sclerosis	1.96e-06	9.09e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—TGFB1—multiple sclerosis	1.96e-06	9.07e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—MAPK1—multiple sclerosis	1.92e-06	8.89e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—IL6—multiple sclerosis	1.77e-06	8.19e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—IL6—multiple sclerosis	1.51e-06	6.98e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—IL6—multiple sclerosis	1.47e-06	6.83e-06	CbGpPWpGaD
